If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (4.831%)
Market Cap: £65.92m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Circ re. Enhanced Buyback Scheme

21 Sep 2012 14:17

RNS Number : 8878M
Maven Income and Growth VCT 3 PLC
21 September 2012
 

MAVEN INCOME & GROWTH VCT 3 PLC

PUBLICATION OF CIRCULAR

Summary

The board of directors ("Board") of Maven Income & Growth VCT 3 plc ("the Company") is today sending out a circular ("Circular") to shareholders in relation to the proposed enhanced buyback scheme in respect of the ordinary shares of 10p each in thecapital of the Company ("Shares"), such scheme being for up to 14.99% of the issued share capital of the Company ("Enhanced Buyback Scheme").

 

The Enhanced Buyback Scheme is subject to shareholder approval being provided at a general meeting convened for 16 October 2012pursuant to the Circular. The Enhanced Buyback Scheme has opened today for application.

Enhanced Buyback Scheme

The Company is offering to purchase up to a maximum of 4,708,596 existing Shares, which represent 14.99% of the issued share capital as at 21 September 2012, subject to the proceeds of sale being reinvested in new Shares.

The record date to be eligible to participate in the Enhanced Buyback Scheme is 5.00 p.m. on 21 September 2012.

The closing date for applications pursuant to the Enhanced Buyback Scheme is 12.00 noon on 29 October 2012.

If the Enhanced Buyback Scheme is over subscribed, applications will be scaled back and accepted as follows:

Firstly, valid applications from all shareholders eligible to participate would be accepted to the extent that the number of Existing Shares to be purchased represent 14.99% or less of their holding of Existing Shares on 21September 2012 (rounded down to the nearest whole number of Existing Shares) and secondly, valid applications thereafter would be accepted pro rata to the number of Existing Shares tendered, subject always to the Board's discretion.

Further details on the Enhanced Buyback Scheme, including the terms and conditions and tax consequences of participating, are set out in the Circular and application form. Shareholders are further advised to consult their independent financial adviser.

Availability of Documents

The Circular has been submitted to the Financial Services Authority and will shortly be available for inspection both at the National Storage Mechanism, which is located at:

 

http://www.hemscott.com/nsm.do

 

and the Company's website:

 

http://www.mavencp.com/migvct3

 

Rosemary O'Neil

Maven Capital Partners UK LLP

0141 306 7400

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CIRUAAORUNAKUAR
Date   Source Headline
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares
31st Oct 20223:54 pmRNSTransaction in Own Shares
21st Oct 20222:45 pmRNSNet Asset Value(s)
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
26th Aug 202210:04 amRNSIssue of Equity
22nd Aug 20229:33 amRNSStatement re Dividend Investment Scheme
29th Jul 202211:25 amRNSHalf-year Report
21st Jul 20224:38 pmRNSTransaction in Own Shares
13th Jul 202211:19 amRNSNet Asset Value and Interim Dividend
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
6th Jun 20222:15 pmRNSIssue of Equity
26th May 20225:02 pmRNSTransaction in Own Shares
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
26th Apr 202210:51 amRNSIssue of Equity - Dividend Investment Scheme
21st Apr 20222:39 pmRNSStatement re Dividend Investment Scheme
6th Apr 20224:02 pmRNSNet Asset Value(s)
6th Apr 20221:45 pmRNSResult of AGM
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.